1. Home
  2. INTS vs RAYA Comparison

INTS vs RAYA Comparison

Compare INTS & RAYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INTS
  • RAYA
  • Stock Information
  • Founded
  • INTS 2012
  • RAYA 2019
  • Country
  • INTS United States
  • RAYA China
  • Employees
  • INTS N/A
  • RAYA N/A
  • Industry
  • INTS Biotechnology: Pharmaceutical Preparations
  • RAYA Metal Fabrications
  • Sector
  • INTS Health Care
  • RAYA Consumer Discretionary
  • Exchange
  • INTS Nasdaq
  • RAYA Nasdaq
  • Market Cap
  • INTS 33.4M
  • RAYA 35.3M
  • IPO Year
  • INTS 2023
  • RAYA 2022
  • Fundamental
  • Price
  • INTS $2.13
  • RAYA $1.27
  • Analyst Decision
  • INTS Strong Buy
  • RAYA
  • Analyst Count
  • INTS 3
  • RAYA 0
  • Target Price
  • INTS $8.50
  • RAYA N/A
  • AVG Volume (30 Days)
  • INTS 35.4K
  • RAYA 5.1K
  • Earning Date
  • INTS 03-13-2025
  • RAYA 01-01-0001
  • Dividend Yield
  • INTS N/A
  • RAYA N/A
  • EPS Growth
  • INTS N/A
  • RAYA N/A
  • EPS
  • INTS N/A
  • RAYA N/A
  • Revenue
  • INTS N/A
  • RAYA $22,816,585.00
  • Revenue This Year
  • INTS N/A
  • RAYA $64.53
  • Revenue Next Year
  • INTS N/A
  • RAYA $9.61
  • P/E Ratio
  • INTS N/A
  • RAYA N/A
  • Revenue Growth
  • INTS N/A
  • RAYA N/A
  • 52 Week Low
  • INTS $1.50
  • RAYA $0.55
  • 52 Week High
  • INTS $5.94
  • RAYA $1.78
  • Technical
  • Relative Strength Index (RSI)
  • INTS 42.33
  • RAYA 48.81
  • Support Level
  • INTS $2.20
  • RAYA $1.22
  • Resistance Level
  • INTS $2.53
  • RAYA $1.28
  • Average True Range (ATR)
  • INTS 0.33
  • RAYA 0.06
  • MACD
  • INTS -0.01
  • RAYA -0.00
  • Stochastic Oscillator
  • INTS 36.76
  • RAYA 26.09

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with major unmet medical need.

About RAYA Erayak Power Solution Group Inc.

Erayak Power Solution Group Inc engages in manufacturing, research and development, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery, and smart chargers, and custom-designed products. It derives the majority revenue from three products namely inverters, chargers, and gasoline generators. The company geographically operates in China, Australia, Poland, U.K., and Germany. It derives maximum revenue from China.

Share on Social Networks: